Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: An Open-Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162) in Subjects With Recurrent or Unresectable Giant Cell Tumor (GCT) of Bone
Brief Summary: To determine how safe and effective denosumab is in treating patients with giant cell tumor of bone.